Hangzhou Coco Healthcare Products Co.Ltd. (301009) — Net Asset Quality Index
Hangzhou Coco Healthcare Products Co.Ltd. (301009) has a Net Asset Quality Index of 65.6% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥2.15 Billion minus total liabilities of CN¥739.23 Million yields net assets of CN¥1.41 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See Hangzhou Coco Healthcare Products Co.Ltd (301009) defensive interval to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Hangzhou Coco Healthcare Products Co.Ltd. Net Asset Quality Index Over Time (2017–2024)
This chart shows how Hangzhou Coco Healthcare Products Co.Ltd.'s Net Asset Quality Index has evolved across 8 annual periods from 2017 to 2024. As of September 2025, the index stands at 65.6%, representing net assets of CN¥1.41 Billion against total assets of CN¥2.15 Billion CNY. Explore Hangzhou Coco Healthcare Products Co.Ltd cash conversion from operations to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Hangzhou Coco Healthcare Products Co.Ltd. (2017–2024)
The table below presents the year-by-year Net Asset Quality Index for Hangzhou Coco Healthcare Products Co.Ltd. from 2017 to 2024, covering 8 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Hangzhou Coco Healthcare Products Co.Ltd stock valuation.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 67.6% | CN¥1.41 Billion | CN¥2.09 Billion | CN¥678.06 Million | ▼ -5.2 pp |
| 2023 | 72.8% | CN¥1.45 Billion | CN¥1.99 Billion | CN¥542.40 Million | ▼ -0.7 pp |
| 2022 | 73.5% | CN¥1.43 Billion | CN¥1.95 Billion | CN¥516.88 Million | ▲ +1.2 pp |
| 2021 | 72.3% | CN¥1.51 Billion | CN¥2.09 Billion | CN¥578.59 Million | ▲ +26.6 pp |
| 2020 | 45.6% | CN¥681.55 Million | CN¥1.49 Billion | CN¥812.42 Million | ▲ +2.9 pp |
| 2019 | 42.7% | CN¥458.05 Million | CN¥1.07 Billion | CN¥613.89 Million | ▼ -11.0 pp |
| 2018 | 53.8% | CN¥535.64 Million | CN¥996.27 Million | CN¥460.64 Million | ▲ +4.4 pp |
| 2017 | 49.4% | CN¥472.55 Million | CN¥957.14 Million | CN¥484.59 Million | — |